News
BIO
305.27
+0.75%
2.28
Weekly Report: what happened at BIO last week (1222-1226)?
Weekly Report · 12/29/2025 09:38
Tracking John Rogers' Ariel Investments Portfolio - Q3 2025 Update
Seeking Alpha · 12/24/2025 00:58
CareDX Has Reached An Inflection Point, But Regulatory Risks Remain (Upgrade)
Seeking Alpha · 12/22/2025 15:15
Weekly Report: what happened at BIO last week (1215-1219)?
Weekly Report · 12/22/2025 09:38
Is Bio-Rad (BIO) Quietly Repositioning Its Moat Around Automation‑Led Blood Diagnostics?
Simply Wall St · 12/15/2025 14:18
Bio-Rad Laboratories (BIO) Gets a Hold from Wells Fargo
TipRanks · 12/15/2025 11:55
Weekly Report: what happened at BIO last week (1208-1212)?
Weekly Report · 12/15/2025 09:41
Weekly Report: what happened at BIO last week (1201-1205)?
Weekly Report · 12/08/2025 09:41
A Look at Bio-Rad Laboratories’s Valuation Following New StarBright Dye Launch for Flow Cytometry
Simply Wall St · 12/01/2025 11:23
Weekly Report: what happened at BIO last week (1124-1128)?
Weekly Report · 12/01/2025 09:39
Does Bio-Rad’s Expanded StarBright Dye Line Shift the Innovation Narrative for BIO?
Simply Wall St · 11/29/2025 21:22
3 Stocks Flashing ‘Buy’ Alerts for Investors on Technical Charts
TipRanks · 11/25/2025 13:47
Weekly Report: what happened at BIO last week (1117-1121)?
Weekly Report · 11/24/2025 09:41
Weekly Report: what happened at BIO last week (1110-1114)?
Weekly Report · 11/17/2025 09:42
Is Bio-Rad’s Third Quarter Net Loss and Share Buyback Shaping the Investment Case for BIO?
Simply Wall St · 11/12/2025 07:22
Bio-Rad Laboratories (BIO): Assessing Valuation Following Q3 Loss and Share Buyback Completion
Simply Wall St · 11/11/2025 02:24
Top Executive Sells Bio-Rad Laboratories Stock in Major Transaction
TipRanks · 11/11/2025 02:13
Goldman says healthcare is ripe for stock picking; here's some they like
Seeking Alpha · 11/10/2025 16:19
Weekly Report: what happened at BIO last week (1103-1107)?
Weekly Report · 11/10/2025 09:40
Weekly Report: what happened at BIO last week (1027-1031)?
Weekly Report · 11/03/2025 09:39
More
Webull provides a variety of real-time BIO stock news. You can receive the latest news about Bio Rad Labs Inc through multiple platforms. This information may help you make smarter investment decisions.
About BIO
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.